What is SOLACI?

LATIN AMERICAN SOCIETY OF INTERVENTIONAL CARDIOLOGY

The Latin American Society of Interventional Cardiology (SOLACI) was created to advance and promote cardiovascular intervention in Latin America and the Caribbean. Since 1993, SOLACI has strived for excellence through several strategies that include education and training, research promotion, guidelines development, regular meetings, regional sessions, and constant exchange between members.

Today, SOLACI represents hemodynamics in 20 countries, has more than 2000 active members and strong alliances with the main interventional cardiology societies, both regional and international; among others, ESC (European Society of Cardiology), SCAI (Society for Cardiovascular Angiography and Interventions), ACC (American College of Cardiology), EAPCI ( European Association of Percutaneous Cardiovascular Interventions), CRF (Cardiovascular Research Foundation), and Sociedad Española de Cardiología (SEC).

OUR VALUES

SOLACI aims at the integration of the Latin American and the Caribbean countries, the promotion of education, and the growth of interventional cardiology, fostering professional cooperation among our experts, encouraging imagination and supporting the development of interventional cardiologists in our region.

We remain faithful to the history and ideals of our Society, in keeping with our strong ethical values of solidarity and integration..

OUR HUMAN CAPITAL

Throughout Latin America, we have the unconditional support of medical and administrative personnel decidedly committed to the Mission and Vision of SOLACI.

Become a member of SOLACI

More articles by this author

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

Esta es una entrada en ingles

demo en ingles

test eng

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...